Macquarie Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $65.2M | Buy |
2,321,799
+409,252
| +21% | +$10.9M | 0.39% | 54 |
|
|
2025
Q4 | $47.5M | Sell |
1,912,547
-628,927
| -25% | -$15.9M | 0.21% | 92 |
|
|
2025
Q3 | $64.8M | Sell |
2,541,474
-246,157
| -9% | -$6.08M | 0.08% | 351 |
|
|
2025
Q2 | $67.5M | Sell |
2,787,631
-2,004,033
| -42% | -$46.7M | 0.08% | 334 |
|
|
2025
Q1 | $121M | Sell |
4,791,664
-2,489,880
| -34% | -$65.2M | 0.15% | 184 |
|
|
2024
Q4 | $148M | Buy |
7,281,544
+1,857,664
| +34% | +$50.4M | 0.18% | 148 |
|
|
2024
Q3 | $157M | Sell |
5,423,880
-534,889
| -9% | -$15.6M | 0.17% | 149 |
|
|
2024
Q2 | $167M | Buy |
5,958,769
+248,472
| +4% | +$6.84M | 0.19% | 130 |
|
|
2024
Q1 | $158M | Buy |
5,710,297
+491,830
| +9% | +$13.6M | 0.18% | 144 |
|
|
2023
Q4 | $150M | Sell |
5,218,467
-26,281
| -0.5% | -$794K | 0.17% | 150 |
|
|
2023
Q3 | $174M | Sell |
5,244,748
-576,756
| -10% | -$20.4M | 0.22% | 108 |
|
|
2023
Q2 | $213M | Buy |
5,821,504
+1,191,243
| +26% | +$46.4M | 0.24% | 79 |
|
|
2023
Q1 | $189M | Buy |
4,630,261
+469,856
| +11% | +$20.3M | 0.22% | 98 |
|
|
2022
Q4 | $213M | Sell |
4,160,405
-739,709
| -15% | -$35.5M | 0.25% | 75 |
|
|
2022
Q3 | $214M | Sell |
4,900,114
-453,528
| -8% | -$22M | 0.26% | 77 |
|
|
2022
Q2 | $281M | Sell |
5,353,642
-81,012
| -1% | -$4.13M | 0.32% | 61 |
|
|
2022
Q1 | $281K | Sell |
5,434,654
-983,867
| -15% | -$51M | 0.21% | 85 |
|
|
2021
Q4 | $379M | Buy |
6,418,521
+2,006,883
| +45% | +$99.4M | 0.32% | 67 |
|
|
2021
Q3 | $190M | Sell |
4,411,638
-342,616
| -7% | -$15.2M | 0.16% | 149 |
|
|
2021
Q2 | $186M | Sell |
4,754,254
-124,850
| -3% | -$4.86M | 0.15% | 154 |
|
|
2021
Q1 | $177M | Buy |
4,879,104
+831,643
| +21% | +$29.5M | 0.25% | 75 |
|
|
2020
Q4 | $149M | Sell |
4,047,461
-18,923,235
| -82% | -$694M | 0.22% | 100 |
|
|
2020
Q3 | $800M | Sell |
22,970,696
-1,202,423
| -5% | -$42.2M | 1.35% | 2 |
|
|
2020
Q2 | $750M | Sell |
24,173,119
-2,121,859
| -8% | -$72.1M | 1.29% | 4 |
|
|
2020
Q1 | $814M | Sell |
26,294,978
-1,565,171
| -6% | -$53.3M | 1.67% | 3 |
|
|
2019
Q4 | $1.04B | Buy |
27,860,149
+3,167,767
| +13% | +$113M | 1.48% | 3 |
|
|
2019
Q3 | $842M | Buy |
24,692,382
+2,100,322
| +9% | +$76.4M | 1.41% | 8 |
|
|
2019
Q2 | $929M | Sell |
22,592,060
-605,460
| -3% | -$24M | 1.57% | 3 |
|
|
2019
Q1 | $935M | Sell |
23,197,520
-135,476
| -0.6% | -$5.43M | 1.59% | 3 |
|
|
2018
Q4 | $966M | Sell |
23,332,996
-2,177,052
| -9% | -$90.4M | 1.87% | 2 |
|
|
2018
Q3 | $1.07B | Sell |
25,510,048
-1,198,483
| -4% | -$46.1M | 1.74% | 1 |
|
|
2018
Q2 | $919M | Buy |
26,708,531
+4,579,203
| +21% | +$156M | 1.59% | 1 |
|
|
2018
Q1 | $745M | Buy |
22,129,328
+473,534
| +2% | +$16.3M | 1.36% | 4 |
|
|
2017
Q4 | $743M | Sell |
21,655,794
-730,210
| -3% | -$24.9M | 1.31% | 14 |
|
|
2017
Q3 | $758M | Sell |
22,386,004
-2,808,540
| -11% | -$90.3M | 1.36% | 2 |
|
|
2017
Q2 | $803M | Sell |
25,194,544
-822,124
| -3% | -$25.9M | 1.47% | 7 |
|
|
2017
Q1 | $844M | Buy |
26,016,668
+240,739
| +0.9% | +$7.59M | 1.53% | 2 |
|
|
2016
Q4 | $794M | Buy |
25,775,929
+1,944,991
| +8% | +$59.4M | 1.52% | 9 |
|
|
2016
Q3 | $766M | Sell |
23,830,938
-23,231,336
| -49% | -$777M | 1.47% | 4 |
|
|
2016
Q2 | $1.57B | Buy |
47,062,274
+23,590,041
| +101% | +$753M | 1.54% | 4 |
|
|
2016
Q1 | $660M | Buy |
23,472,233
+2,787,928
| +13% | +$79.6M | 1.33% | 23 |
|
|
2015
Q4 | $634M | Buy |
20,684,305
+438,335
| +2% | +$13.8M | 1.3% | 15 |
|
|
2015
Q3 | $603M | Buy |
20,245,970
+338,330
| +2% | +$10.8M | 1.29% | 12 |
|
|
2015
Q2 | $633M | Sell |
19,907,640
-57,532
| -0.3% | -$1.88M | 1.25% | 6 |
|
|
2015
Q1 | $659M | Sell |
19,965,172
-145,652
| -0.7% | -$4.63M | 1.29% | 3 |
|
|
2014
Q4 | $594M | Buy |
20,110,824
+525,802
| +3% | +$15.1M | 1.23% | 3 |
|
|
2014
Q3 | $549M | Buy |
19,585,022
+2,050,206
| +12% | +$57.5M | 1.18% | 3 |
|
|
2014
Q2 | $494M | Buy |
17,534,816
+1,805,591
| +11% | +$51.5M | 1.1% | 5 |
|
|
2014
Q1 | $479M | Buy |
15,729,225
+23,858
| +0.2% | +$711K | 0.83% | 22 |
|
|
2013
Q4 | $456M | Buy |
15,705,367
+786,331
| +5% | +$22.9M | 0.82% | 24 |
|
|
2013
Q3 | $406M | Buy |
14,919,036
+1,134,509
| +8% | +$30.9M | 0.79% | 24 |
|
|
2013
Q2 | $366M | Buy |
+13,784,527
| New | +$381M | 0.8% | 25 |
|
Other funds holding PFE
VCM
VPM
Macquarie Group's PFE Position: Q1 2026 in Review
Macquarie Group increased its Pfizer (PFE) stake by 21% in Q1 2026, buying an estimated $10.9M and bringing the position to 2,321,799 shares worth $65.2M. The position accounts for 0.39% of the portfolio, ranked #54.
Macquarie Group first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.57B in Q2 2016. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Macquarie Group held 2,321,799 shares of Pfizer worth $65.2M as of Q1 2026.
- Macquarie Group bought 409,252 Pfizer shares in Q1 2026, an estimated $10.9M.
- Pfizer made up 0.39% of Macquarie Group's portfolio in Q1 2026, its #54 holding.
- Macquarie Group first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Macquarie Group's Pfizer position peaked at $1.57B in Q2 2016.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Macquarie Group's 13F filing for Q1 2026, filed 15 May 2026.